Search

everythinglearnresearchcommunity

for

Search:↓

Targeting specific T cells may help treat alopecia areata.

Vitamin D receptor is essential for proper skin healing after injury.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Hair loss in men may be caused by inflammation triggered by hormones, and treatments reducing inflammation could potentially promote hair growth.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Higher CRHR1 levels in AA patients lead to increased inflammation.

Simvastatin reduces inflammation and promotes hair regrowth in alopecia areata.

JAK inhibitors show promise for treating skin diseases effectively and safely.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Regulatory T cells protect hair follicle stem cells by maintaining immune privilege in the skin.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

miR-486 may help prevent hair loss in alopecia areata.

JAK-inhibitors are effective for treating psoriasis and show promise for other skin diseases.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

The rash worsened due to a fungal infection masked by corticosteroids.

The child was diagnosed with a skin condition involving inflamed hair follicles.

Anti-MND antibodies are present in various diseases, not just PBC, and their levels don't correlate with disease activity or skin symptoms.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

Old neuropharmacological drugs might be effective for treating inflammatory skin diseases.

Different γδ T cell types have unique roles in causing alopecia areata.

An 18-year-old girl with pemphigus vulgaris needed strong medication and careful treatment due to ineffective initial therapies and side effects.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

Calcineurin inhibitors, used in kidney transplants, can cause a wide range of side effects including kidney damage and other health issues.

New treatments for atopic dermatitis and alopecia areata have been developed using a targeted approach.

New targeted therapies for psoriasis show promise but face challenges like side effects and treatment resistance.